STAAR Surgical: The Winning Streak Continues (STAA)
STAAR Surgical (NASDAQ:STAA) traded at a new 52-week high today of $11.65. This new high was reached on above average trading volume as 238,000 shares traded hands, while the average 30-day volume is approximately 170,000 shares.
STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient's quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.
Over the past year, STAAR Surgical has traded in a range of $4.96 to $11.65 and is now at $11.63, 134% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.7% while the 50-day MA has advanced 1.1%.
STAAR Surgical (NASDAQ:STAA) defies analysts with a current price ($11.63) 16.2% above its average consensus price target of $9.75. STAAR Surgical shares have support at the 50-day moving average (MA) of $9.93 and additional support at the 200-day MA of $7.01.
SmarTrend recommended that subscribers consider buying shares of STAAR Surgical on January 2nd, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $6.33. Since that recommendation, shares of STAAR Surgical have risen 66.0%. We continue to monitor STAA for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows staar surgical